(PharmaNewsWire.Com, July 14, 2017 ) Europe Regenerative Medicines by Product, Therapy, and Application Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis and Forecasts (2016 to 2021) As per the syndicated report published by Market Data Forecast, Europe Regenerative Medicines Market which is estimated to be USD 5.06 bbillion in 2016 and expected to grow at a CAGR of 21.80%, to reach USD 13.56 billion by 2021 with a cumulative growth rate of USD 8.50 billion in the span of five years.
It can attributed to the factors such as increasing aging population, growing number of life style disorders (diabetes, obesity), rising advancements in the research & development, increasing number of people suffering from chronic disorders (such as liver diseases, blood disorders), and growing involvement of government to help research institutes for the development of regenerative medicines. However, presence of uncertain regulatory guidelines and stringent ethical laws to conduct research & developments in tissue engineered products & cell-based products are restraining the growth of regenerative medicines market in Europe.
Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs. Regenerative Medicine is working to improve the quality of life for patients all over the world. Scientists work with this powerful technology to create new body parts from a patients own cells and tissues. Success of these efforts will eliminate the concept of tissue rejection.
Europe Regenerative Medicines Market is segmented based on product, therapy and application below for obtaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts. Product Cell-Based Products Autologous Cell-Based Products Allogeneic Cell-Based Products Acellular Products Therapy Cell Therapy Gene Therapy Tissue Engineering Immunotherapy Application Orthopedic & Musculoskeletal Spine Dermatology Cardiovascular Central Nervous System Oncology Diabetes Other Applications
Europe is an amalgamation of major economies like Germany, Spain, Italy, U.K. and France among others to name a few. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well (Rest of Europe).
The key players in regenerative medicines market such as, Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia).
The Regenerative Medicines market study offers the following deliverables: Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Europe Pharmaceuticals Segment:
About Us: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
